Independent Review Committee

in page functions

Gavi has established an Independent Review Committee for the review of new proposals

To support an independent and systematic process of reviewing new proposals, Gavi has established an Independent Review Committee (IRC).

Key characteristics

Since its inception, the structure and composition of the Gavi IRC have been considered effective due to key characteristics:

  • the committee relies upon a wide range of experts in public health, epidemiology, development, finance and economics;
  • the committee is based on a system of peer review; and
  • the committee is independent.

The Gavi Board

The IRC is directly accountable to the Gavi Board and communicates its recommendations to the Gavi Board. The Gavi Board makes the ultimate decision on whether to approve the funding of new country grants. The Gavi Board also has the responsibility for communicating its decision to countries, via the Gavi Secretariat.

Keeping in mind the realistic planning timelines, countries should target a submission deadline that meets their implementation timelines.

 

Round 1  

Round 2  

Round 3  

Submission cut-off dates

22 January 2019

1 May 2019

4 September 2019

Review dates (indicative)

11-22 March 2019

1–12 July 2019

28 Oct - 8 Nov 2019

The Independent Review Committee reviews new proposals and makes recommendations to the Gavi Board

The mandate of the new proposals IRC is to review each application for all types of new support, to enable a more holistic view of the broad portfolio of support Gavi provides to countries, rather than looking at each new application in isolation from the others, and to make recommendations to the Gavi Board.

This review should consider the information available to countries within current guidelines and application forms and ensure that any new proposal contributes to achieving:

  • the Gavi mission - ‘To save children’s lives and protect people’s health by increasing access to immunisation in poor countries’;
  • the Gavi's strategic goals; and
  • the eligibility criteria as per Gavi guidelines for new proposals of support.

Members of the Independent Review Committee consist of specialists from a broad range of expertise

IRC members generally serve a term of three years. This term may be renewed for another period of up to 3 years. Upon reaching the second term limit IRC members will not be eligible to serve on the IRC for at least 1 year. During their term IRC members may be called upon to serve on the IRC for review of country plans or requests for extensions for which he or she has specific relevant skills.

Click here to view Terms of Reference for the Gavi Independent Review Committee  

Range of expertise

The increasing complexity of new proposals and the subsequent grant monitoring requires an IRC with a broad range of expertise in areas such as:

  • Routine immunisation programmes, especially at country level;
  • Management of campaigns;
  • Delivery of health services including child and adolescent health;
  • Health systems strengthening and management;
  • Epidemiology and disease control;
  • Cold chain and logistics;
  • Financial and budget analysis; and
  • Gender and equity.

The IRC should also consist of technical experts knowledgeable on the developing country context and relevant issues, including in a variety of fields related to immunisation and health systems, and who have practical experience working in or with developing country governments, civil society, and other partners in those contexts. In addition, the IRC should be geographically diverse, with a male and female representation consistent with Gavi’s Gender Policy and Guidelines on the Gavi Board Gender Balance.

Each IRC member is asked to sign a confidentiality and conflict of interest statement and will not come from Vaccine Alliance partner agencies, and have not taken part in technical assistance to or pre-review processes of country applications.

List of IRC pool members

Click here to view the biographies of the IRC members  

 

Name  

Areas of expertise  

1

Emmanuel Addo-Yobo

Child health; clinical paediatrics; surveillance for rotavirus and congenital rubella syndrome

2

Salah Al Awaidy

Vaccine-preventable diseases programming, epidemiology, public health, immunisation, M&E, AEFI, Measles, Rubella, MR campaign, MenA, Rota and HPV

3

Rafah Salam Aziz

MNCH programme management, immunisation

4

Alejo Bejemino

Cold chain/Supply chain and logistics Management

5

Annette Bongiovanni

Programme management, monitoring and evaluation, and operations research

6

Brent Burkholder

Epidemiology, vaccine programmes and disease control, outbreak investigations

7

Diego Buriot

Public health interventions, communicable diseases, fragile and crisis settings

8

Pierre Bwale

Health care delivery, campaigns, emergencies, programmes for hard-to-reach communities

9

Lisa Cairns

Immunisation policy, epidemiology, M&R control, national immunisation programme reviews

10

Aleksandra Caric

Immunisation, vaccine safety and regulation, programme management and administration

11

Gabriel Carrasquilla

Epidemiology, immunisation programmes

12

Amos Chweya

Public health logistics, procurement and logistics management of immunisation activities

13

Sadia Chowdhury

Reproductive Health, HSS, child health services, programme delivery, M&E of health programmes

14

John Clements

Routine immunisation services in developing countries

15

Natasha Crowcroft

Epidemiology, HSS, HPV, measles, outbreak control, training and capacity building

16

Dora Curry

CSOs, data systems at community and primary care level, data utilization for programme improvement

17

Celestino Costa

Cold chain, immunisation, HSS, emergency responses, primary health care

18

John Crump

Infectious diseases, epidemiology, outbreak responses, typhoid

19

Henrique D’Alva

Cold chain, EPI logistics

20

Kevin De Cock

Global public health, HIV, emergency & outbreak response, HSS

21

Modibo Dicko

Supply chain management, introducing innovative technologies, management systems and practices in health supply systems

22

Abdoulaye Oumar Djigo

Management, logistics in health sector, engineering (cold chain, biomedical equipment, energy efficiency, environment)

23

Linda Eckert

Vaccines, especially in the intersection of immunisation with reproductive health

24

Marta Feletto

Gender equality, M&E, immunisation programme, HPV

25

Djordie Gikic

HSS, proposal development, immunisation systems evaluation, service delivery, health policies

26

Melita Gordon

Gastroenterology, disease surveillance, typhoid, vaccine trials

27

John Grundy

Health policy, campaign delivery, HSS, programme evaluation

28

Terence Hart

Immunisation supply chain and logistics, environmental sustainability and corporate management

29

Bradley Hersh

Health policy, immunisation, outbreaks, campaigns, measles control

30

Natasha Howard

Health policy, social epidemiology, immunisation service delivery, fragile setting, strong academic background

31

Hector Izurieta

Immunisation campaign management, public health, measles control, epidemiology, policy making

32

Philippe Jaillard

Vaccine delivery, cold chain equipment management, injection safety and waste management, logistics training program development

33

Miloud Kaddar

Health economics, economics of vaccines and immunisation, health system development and financing

34

Kabelwa Kagaruki

General public health, immunisation logistics/supply chain, EPI monitoring and evaluation

35

Clifford Kamara

Health development, immunisation services, recovery programme, management and evaluation of health programmes

36

Jean Rostand Kamga

Financial & budget analysis, management and governance, audits, financial investigations

37

Toagoe Karzon

Project funding, financial reporting and budget control, conducting audits

38

Tcha Landry Kaucley

Cold Chain, vaccine logistics, EPI monitoring & evaluation, public health management

39

Wassim Khrouf

Financial & budget analysis, audits, project assessment

40

Vladimir Lazarevik

Healthcare system transformation, health financing design, health policy development

41

Stefano Lazzari

Outbreak, epidemic and emergency response, HSS, monitoring and evaluation, grant management

42

Dafrossa Lyimo

Immunisation campaign management, public health, health systems management, health policies, disease control

43

Kapil Maithal

Conceptualizing, managing, strategizing and execution of development of vaccines for global use, vaccine advocacy and preparedness

44

Marty Makinen

Health economics, immunisation

45

Osman Mansoor

Immunisation programmes, epidemiology & monitoring, measles control, cold chain & logistics

46

Viviana Mangiaterra

Child health, epidemiology, HSS, immunisation programmes

47

Claude Mangobo

Management of cold chain equipment and vaccine management, maintenance and installation of solar cold chain equipment

48

Florian Marks

Public health, vaccinology and policy making, outbreak responses, campaign evaluations

49

Tawanda Marufu

Fragile settings, HSS, epidemiology, health policy, HPV, Typhoid, measles

50

Mark Miller

Epidemiology, vaccine research, public health, outbreak investigations, disease control

51

Sandra Mounier-Jack

Immunisation programmes, health systems strengthening, HPV vaccine, measles elimination, health policy and health financing

52

Kondwani Msampha

Financial & budget analysis, HSS, global health and integrated service delivery

53

Amani Mustafa

Immunisation, new vaccines, campaign management, cold chain and health system planning and monitoring

54

Maryanne Neill

Health information systems, cold chain logistics, immunisation coverage estimation.

55

Benjamin Nkowane

Vaccine preventable disease programmes, implementation of mass vaccination campaigns, technical support for field operations in security risk areas, epidemiology and reproductive/sexual health

56

Peter Nsubuga

Epidemiology, measles control, cold chain, HSS

57

Frank Nyonator

Health systems and health service provision

58

Jean Marc Olive

Immunisation programmes, emergency strategies & disaster relief, measles elimination

59

Adepeju Olukoya

Gender, women and health, sexual and reproductive health, health systems

60

Virgil Onama

Project design, M&E, results-based management, health financing & policy, fragile settings

61

Bolanle Oyeledun

HSS, MNCH, immunisation, adolescent reproductive health & HPV, programme assessments and evaluations

62

Koyejo Oyerinde

Paediatrics, health systems strengthening

63

Michael Park

Programme management and evaluation, primary care, health systems and public health

64

Zeenat Patel

Epidemiology, communicable disease control/outbreak preparedness, sexual & reproductive health, NVS Introduction, campaigns, IMNCI/iCCM (pneumonia, diarrhoea and malaria programming)

65

Ian Pett

Health care, cold chain, HSS, outbreak response, emergencies

66

Arletty Pinel

Health systems strengthening, maternal health

67

Robert (Bob) Pond

Health systems strengthening, data quality assessment, epidemiology

68

Kshem Prasad

Evaluation of programme logistics, assessments of immunisation supply chain and development of plans for system strengthening

69

Arthur Reingold

Epidemiology, measles control, vaccination delivery, strengthening health infrastructure

70

Diana Rivington

Gender equality, human rights, children’s rights

71

Cheikh Mohamed Hafis Seck

Financial & budget analysis, financial management of donor-funded programs, audit, grant agreements

72

Craig Shapiro

Management of immunisation programmes, policy development, public health, cold chain evaluation, HSS activities

73

Mario Stassen

Design of development strategies, risk based management and patient safety, immunisation supply chain logistics (cold chain), CMC (Bio) Pharmaceuticals

74

Simon (Sam) Sternin

Global health generalist, HSS, disaster management, coverage and equity, CSOs

75

Ousmane Amadou Sy

Health and community systems strengthening, grant management support, financial management, organizational development

76

Michael Thiede

Health economics, health policy and health systems, procurement and logistics

77

Abdelmajid Tibouti

Financial & budget analysis, health economics, health financing strategies, monitoring and evaluation

78

Asnakew Tsega

Public health, epidemiology, programme management, monitoring and evaluation

79

Vivien Tsu

Epidemiology, new public health interventions, women's reproductive health, HPV, JE

80

Beena Varghese

Costing and evaluation of MNCH interventions, analysis of health system level issues in MNCH

81

Abdul G. Wali

Policy and strategy development, health information management, assessments, HSS, immunisation

82

Margaret Watkins

Immunisation campaign management, epidemiology, public health interventions, outbreaks, evaluations

83

Karen Wilkins

Immunisation campaign management, proposals development, monitoring and evaluation, DQ assessments

84

Charles Shey Umaru Wiysonge

Vaccinology, systematic reviews, programme management

85

Aregai Woldegebriel

Epidemiology, SIA, MNCH, outbreaks, monitoring and evaluation

86

Shamsa Zafar

MNCH, Gender

Country portal

Applying for or receiving Gavi support? Visit our country portal.  

US$ 80-100 billion

Investing in Gavi’s 2016-2020 strategy has the potential to deliver US$ 80-100 billion in costs averted related to illness, such as productivity loss due to death/disability, treatment costs, caretaker productivity loss and transport costs.

Stack M et al. Estimated economic benefits during Decade of Vaccines, Health Affairs 2011

More facts...

close icon

modal window here